Genetic testing and biotechnology company 23andme has applied for bankruptcy. The company, which started in 2006, was struggling with difficulties for a long time. Earlier, it had to face trial about data breech. After this, independent directors resigned from its board. With this, due to the closure of the drug development division, the company’s difficulties started increasing and now the company is looking for potential buyers. In such a situation, the big concern is about the data of crores of people present with the company. Now the question is being…
Read More23andme filed for bankruptcy what will happen to users genetic data
